Company news

Artivion, Inc. news in 2025

Artivion, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Artivion Reports Third Quarter 2025 Financial Results

November 6, 2025

Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial

November 6, 2025

Artivion to Participate in the Stifel 2025 Healthcare Conference

October 29, 2025

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results

October 23, 2025

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

October 13, 2025

Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

September 5, 2025

Artivion Reports Second Quarter 2025 Financial Results

August 7, 2025

Artivion to Participate in Upcoming Investor Conferences

July 30, 2025

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results

July 24, 2025

Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

May 28, 2025

Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

May 14, 2025

Artivion Reports First Quarter 2025 Financial Results

May 5, 2025

Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting

May 5, 2025

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results

April 21, 2025

Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

March 4, 2025

Artivion Reports Fourth Quarter and Full Year 2024 Financial Results

February 24, 2025

Calls in 2025

Decks in 2025